DLBS-3233

N/A

Report date: 2025/12/19 16:59:32

Base Information

Drug NameDLBS-3233
Drug Alias NameInlacinDLBS-32DLBS-3233
ClassificationNatural product/Extract > Plants extract
Mechanisms of ActionInsulin sensitizersAdiponectin stimulants
TargetsAdiponectin
Therapy Area/IndicationsPrediabetic StateDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2011/01/01
Country/TerritoryIndiaIndonesia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDexa Medica
China Registration ClassN/A

Develop Information

Active CompaniesDexa Medica
Inactive CompaniesDexa Medica Group
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsPrediabetic State

Other Information

ATC CodeA10X
Related LinksN/A